Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2023 Earnings Call Transcript

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2023 Earnings Call Transcript May 9, 2023

Halozyme Therapeutics, Inc. misses on earnings expectations. Reported EPS is $0.47 EPS, expectations were $0.48.

Operator: Good afternoon, my name is Chris and I’ll be your conference operator today. At this time, I’d like to welcome everyone to the Halozyme First Quarter 2023 Financial and Operating Results Conference Call. All lines have been placed on mute to prevent any background noise. After the...